Prescribing patterns for antihypertensive drugs after the publication of the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) in Region Emilia Romagna (RER), Italy

被引:0
|
作者
Maio, V [1 ]
Yuen, EJ [1 ]
Smith, KD [1 ]
Louis, DZ [1 ]
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA
关键词
D O I
10.1016/S1098-3015(10)64695-5
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A126 / A126
页数:1
相关论文
共 50 条
  • [21] Baseline characteristics of participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Grimm, RH
    Margolis, KL
    Papademetriou, V
    Cushman, WC
    Ford, CE
    Bettencourt, J
    Alderman, MH
    Basile, JN
    Black, HR
    DeQuattro, V
    Eckfeldt, J
    Hawkins, CM
    Perry, HM
    Proschan, M
    HYPERTENSION, 2001, 37 (01) : 19 - 27
  • [22] Heart failure results in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Davis, B
    EUROPEAN HEART JOURNAL, 2004, 25 : 122 - 122
  • [23] Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT])
    Alderman, Michael H.
    Davis, Barry R.
    Piller, Linda B.
    Ford, Charles E.
    Baraniuk, M. Sarah
    Pressel, Sara L.
    Assadi, Mahshid A.
    Einhorn, Paula T.
    Haywood, L. Julian
    Ilamathi, Ekambaram
    Oparil, Suzanne
    Retta, Tamrat M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (01): : 105 - 115
  • [24] The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
    Beevers, DG
    Lee, KW
    Lip, GYH
    JOURNAL OF HUMAN HYPERTENSION, 2003, 17 (06) : 367 - 372
  • [25] Mortality and Morbidity During and After the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    Cushman, William C.
    Davis, Barry R.
    Pressel, Sara L.
    Cutler, Jeffrey A.
    Einhorn, Paula T.
    Ford, Charles E.
    Oparil, Suzanne
    Probstfield, Jeffrey L.
    Whelton, Paul K.
    Wright, Jackson T., Jr.
    Alderman, Michael H.
    Basile, Jan N.
    Black, Henry R.
    Grimm, Richard H., Jr.
    Hamilton, Bruce P.
    Haywood, L. Julian
    Ong, Stephen T.
    Piller, Linda B.
    Simpson, Lara M.
    Stanford, Carol
    Weiss, Robert J.
    JOURNAL OF CLINICAL HYPERTENSION, 2012, 14 (01): : 20 - 31
  • [26] The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
    D G Beevers
    K W Lee
    G Y H Lip
    Journal of Human Hypertension, 2003, 17 : 367 - 372
  • [27] Clinical outcomes in participants with cardiovascular dysmetabolic syndrome in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Black, H
    Davis, B
    JOURNAL OF HYPERTENSION, 2005, 23 : S146 - S146
  • [28] Baseline Quality of Life and Risk of Stroke in the ALLHAT Study (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
    Shams, Tanzila
    Auchus, Alexander P.
    Oparil, Suzanne
    Wright, Clinton B.
    Wright, Jackson
    Furlan, Anthony J.
    Sila, Cathy A.
    Davis, Barry R.
    Pressel, Sara
    Yamal, Jose-Miguel
    Einhorn, Paula T.
    Lerner, Alan J.
    STROKE, 2017, 48 (11) : 3078 - +
  • [29] The relation of hypokalemia at 1 year to morbidity and mortality: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) experience
    Alderman, M.
    Piller, L.
    Ford, C.
    Davis, B.
    Einhorn, P.
    Cushman, W.
    Calhoun, D.
    Eckfeldt, J.
    EUROPEAN HEART JOURNAL, 2005, 26 : 671 - 671
  • [30] Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
    Haywood, L. Julian
    Ford, Charles E.
    Crow, Richard S.
    Davis, Barry R.
    Massie, Barry M.
    Einhorn, Paula T.
    Williard, Angela
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (22) : 2023 - 2031